8(top 1%)
papers
132(top 1%)
citations
6(top 1%)
h-index
8(top 1%)
g-index
18
all documents
188
doc citations
106
citing journals

Top Articles

#TitleJournalYearCitations
1Recruitment of BRCA1 limits MYCN-driven accumulation of stalled RNA polymeraseNature201976
2Risk and Response Adapted Treatment Guidelines for Managing First Relapsed and Refractory Classical Hodgkin Lymphoma in Children and Young People. Recommendations from the EuroNet Pediatric Hodgkin Lymphoma GroupHemaSphere202031
3Phase II-like murine trial identifies synergy between dexamethasone and dasatinib in T-cell acute lymphoblastic leukemiaHaematologica202121
4Ponatinib in childhood Philadelphia chromosome–positive leukaemias: an international registry of childhood chronic myeloid leukaemia studyEuropean Journal of Cancer202019
5Paratesticular rhabdomyosarcoma—Impact of locoregional approach on patient outcome: A report from the European paediatric Soft tissue sarcoma Study Group (EpSSG)Pediatric Blood and Cancer202013
6Outcome of localized liver‐bile duct rhabdomyosarcoma according to local therapy: A report from the European Paediatric Soft‐Tissue Sarcoma Study Group (EpSSG)‐RMS 2005 studyPediatric Blood and Cancer201911
7Epigenetic modulation of neuroblastoma enhances T cell and NK cell immunogenicity by inducing a tumor-cell lineage switchPediatric Blood and Cancer202211
8Development of a pediatric differentiated thyroid carcinoma registry within the EuRRECa project: rationale and protocolEndocrine Connections20232
9Caring for the CarersEndocrine Connections20181
10The EHA Research Roadmap: Normal HematopoiesisHemaSphere20211
11Whole-genome CRISPR screen as a tool to identify mechanism of relapse and potential targets for novel drug combinationsKlinische Padiatrie20200
12Multi-drug chemotherapy dose optimisation in preclinical leukaemia models using HPLC-MS/MSKlinische Padiatrie20200
13Specific targeting of RUNX1/ETO; delivery of siRNA using Lipid Nanoparticles in vitro and in vivoKlinische Padiatrie20200
14Cytogenetics analysis as the central point of genetic testing in acute myeloid leukemia (AML): a laboratory perspective for clinical applicationsClinical and Experimental Medicine00